J. Craig Venter Institute logo

J. Craig Venter Institute

Pioneering Genomics to Positively Impact Life

204 employees · est. 1992 · La Jolla, United States

VS
Precede Biosciences logo

Precede Biosciences

Precede Bio is impacting precision medicine with a first-in-class 🩸 liquid biopsy platform

61 employees · est. 2021 · United States

J. Craig Venter Institute is the older company (1992 vs 2021); J. Craig Venter Institute is the larger of the two.

Side-by-Side Comparison

J. Craig Venter Institute Precede Biosciences
Founded
1992 older 2021
Headquarters
La Jolla, United States United States
Employees
204 larger 61
Industry
Biotechnology, Health Care Not tracked yet
Funding Stage
Grant Series A
Total Funding
$27.40M $120.50M
Funding Rounds
2 2
Services
Not tracked yet Liquid biopsy platform development, Epigenomic analysis and profiling, Diagnostics for cancer and other diseases, Therapeutic target identification, Strategic partnerships with pharmaceutical companies, R&D in precision medicine
Target Customers
Not tracked yet Pharmaceutical companies, Biotech firms, Oncology research institutions, Healthcare providers, Medical diagnostic labs
Taxonomy
Genomic Research, Genomic Medicine, Bioinformatics, Infectious Disease Research, Life Sciences, Mammalian Genomics, Microbial & Environmental Genomics, Synthetic Biology, Bioenergy, Microbial Pathogenesis, Viral Genomics, Informatics Precision Medicine, Liquid Biopsy, Transcriptional Biology, Chromatin Profiling, DNA Methylome, Genomic Medicine, Diagnostic Tests, Drug Development, Cancer Diagnosis, Minimally Invasive Diagnostics, Disease Biology, Machine Learning In Genomics, Artificial Intelligence In Healthcare, Oncology, Genomic Profiling
Website
jcvi.org precede.bio
J. Craig Venter Institute logo

About J. Craig Venter Institute

The J. Craig Venter Institute (JCVI) was established in October 2006 through the consolidation of several related organizations, including The Institute for Genomic Research (TIGR), The Center for the Advancement of Genomics (TCAG), The J. Craig Venter Science Foundation, The Joint Technology Center...

Precede Biosciences logo

About Precede Biosciences

Precede Biosciences, founded in 2021, is at the forefront of precision medicine with its innovative first-in-class liquid biopsy platform. With headquarters in the United States, the company stands out for its commitment to enhance the medical community's understanding of disease-defining biology, o...

We will tell you when either one moves

BounceWatch watches J. Craig Venter Institute and Precede Biosciences for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at J. Craig Venter Instit... and Precede Biosciences — by email.

Frequently Asked Questions

J. Craig Venter Institute — Pioneering Genomics to Positively Impact Life. Precede Biosciences — Precede Bio is impacting precision medicine with a first-in-class 🩸 liquid biopsy platform . Both companies operate in related markets but may differ in funding stage, team size, and product focus.
J. Craig Venter Institute has raised $27.40M while Precede Biosciences has raised $120.50M.
J. Craig Venter Institute and Precede Biosciences operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare J. Craig Venter Institute with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at J. Craig Venter Institute on 9 Jun 2026, and Precede Biosciences on 10 Apr 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes